A pilot study of scalp skin temperature during scalp cooling in patients treated with chemotherapy

A pilot study of scalp skin temperature during scalp cooling in patients treated with chemotherapy - FECtemp

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35108

Enrollment

Registered

2010-05-14

Start date

2010-07-23

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

alopecia hair loss

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Intravenous administered FEC-regimen with an epirubicine dose of 90 mg/m2 or more at 3-weekly intervals, age 18 years or more, written informed consent

Exclusion criteria

Exclusion criteria: Boldness before the start of the study, hematological malignancies with generalized haematogenic metastases and clinical signs of scalp metastases

Design outcomes

Primary

Measure	Time frame
Little is known about the influence of temperature on the outcome of scalp cooling. This pilot study will check the feasibility of the main study, after which specific parameters/outcome will be defined. Hair loss will be measured using the World Health Organisation (WHO) grading system for alopecia and asking the patient whether or not a wig or shawl is required.	—

Secondary

Measure	Time frame
n.v.t.	—

Countries

Netherlands

Outcome results